BK viral disease in renal transplantation

Current Opinion in Organ Transplantation

Volumn 16, Issue 6, 2011, Pages 576-579

  Cannon, Robert M ^a   Ouseph, Rosemary ^a   Jones, Christopher M ^a   Hughes, Michael G ^a   Eng, Mary ^a   Marvin, Michael R ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

BK virus; BK virus associated nephropathy; intravenous immunoglobulin; leflunomide; mammalian target of rapamycin inhibitors

Indexed keywords

CALCINEURIN INHIBITOR; CIDOFOVIR; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN VP1; QUINOLONE DERIVATIVE; RAPAMYCIN; TACROLIMUS; VIRUS DNA;

BK VIRUS; CLINICAL TRIAL (TOPIC); DISEASE SURVEILLANCE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT FAILURE; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MULTICENTER STUDY (TOPIC); NEPHROTOXICITY; PNEUMOCYSTOSIS; POLYOMAVIRUS INFECTION; POSTOPERATIVE COMPLICATION; RETRANSPLANTATION; REVIEW; SCREENING; SERODIAGNOSIS; VIRAL CLEARANCE; VIREMIA; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BK VIRUS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; REOPERATION; TREATMENT OUTCOME; VIRAL LOAD;

EID: 81255135688     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32834cd666     Document Type: Review

References (16)

1. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5:582-594. (Pubitemid 40313351)
2. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virusassociated interstitial nephritis in the allograft kidney. Transplantation 1999; 67:103-109. (Pubitemid 29061146)
3. Drachenberg CB, Hirsch HH, Ramos E, Papadimitriou JC. Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods. Hum Pathol 2005; 36:1245-1255. (Pubitemid 41682279)
4. White LH, Casian A, Hilton R, et al. BK virus nephropathy in renal transplant patients in London. Transplantation 2008; 85:1008-1015. (Pubitemid 351543165)
5. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79:1277-1286. (Pubitemid 40734783)
6. Almeras C, Vetromile F, Garrigue V, et al. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients. Transpl Infect Dis 2011; 13:101-108.
7. Geddes CC, Gunson R, Mazonakis E, et al. BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine- to lower-dose tacrolimus-based primary immunosuppression regimen. Transpl Infect Dis 2011; 13:109-116.
8. Pollara CP, Corbellini S, Chiappini S, et al. Quantitative viral load measurement for BKV infection in renal transplant recipients as a predictive tool for BKVAN. New Microbiol 2011; 34:165-171.
9. Astegiano S, Bergallo M, Terlizzi ME, et al. Combined measurement of serum DNA and urine VP1 messenger RNA in monitoring BK virus replication in kidney graft recipients. Transplant Proc 2011; 43:1052-1054.
10. Renoult E, Coutlee F, Paquet M, et al. Evaluation of a preemptive strategy for BK polyomavirus-associated nephropathy based on prospective monitoring of BK viremia: a kidney transplantation center experience. Transplant Proc 2010; 42:4083-4087.
11. Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus- associated nephropathy. Am J Transplant 2010; 10:2615-2623.
12. Dheir H, Sahin S, Uyar M, et al. Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance. Transplant Proc 2011; 43:867-870.
13. Liacini A, Seamone ME, Muruve DA, Tibbles LA. Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection. Transplantation 2010; 90:1450-1457.
14. Sanchez Fructuoso AI, Calvo N, Perez-Flores I, et al. Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients. Transpl Infect Dis 2011. [Epub ahead of print]
15. Gabardi S, Waikar SS, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol 2010; 5:1298-1304.
16. Geetha D, Sozio SM, Ghanta M, Josephson M, Shapiro R, Dadhania D, et al. Results of repeat renal transplantation after graft loss from BK virus nephropathy. Transplantation 2011. [Epub ahead of print]